nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—obesity	0.659	1	CbGaD
Mivacurium—BCHE—diaphragm—obesity	0.0126	0.217	CbGeAlD
Mivacurium—CHRM3—muscle of abdomen—obesity	0.0124	0.213	CbGeAlD
Mivacurium—CHRND—respiratory system—obesity	0.00524	0.0902	CbGeAlD
Mivacurium—CHRND—cardiovascular system—obesity	0.00401	0.0691	CbGeAlD
Mivacurium—Flushing—Phendimetrazine—obesity	0.00343	0.0281	CcSEcCtD
Mivacurium—Flushing—Phenylpropanolamine—obesity	0.00293	0.024	CcSEcCtD
Mivacurium—Tachycardia—Methamphetamine—obesity	0.00292	0.0238	CcSEcCtD
Mivacurium—Arrhythmia—Phenylpropanolamine—obesity	0.00282	0.0231	CcSEcCtD
Mivacurium—Tachycardia—Benzphetamine—obesity	0.00281	0.023	CcSEcCtD
Mivacurium—Tachycardia—Phendimetrazine—obesity	0.00256	0.021	CcSEcCtD
Mivacurium—Bradycardia—Cimetidine—obesity	0.00255	0.0208	CcSEcCtD
Mivacurium—Urticaria—Methamphetamine—obesity	0.00237	0.0194	CcSEcCtD
Mivacurium—Arrhythmia—Diethylpropion—obesity	0.00235	0.0192	CcSEcCtD
Mivacurium—CHRNA1—endocrine gland—obesity	0.0023	0.0395	CbGeAlD
Mivacurium—Urticaria—Benzphetamine—obesity	0.00229	0.0187	CcSEcCtD
Mivacurium—Erythema—Diethylpropion—obesity	0.00229	0.0187	CcSEcCtD
Mivacurium—CHRNB1—adipose tissue—obesity	0.00228	0.0392	CbGeAlD
Mivacurium—Wheezing—Bupropion—obesity	0.00225	0.0184	CcSEcCtD
Mivacurium—Phlebitis—Sibutramine—obesity	0.00224	0.0183	CcSEcCtD
Mivacurium—Tachycardia—Phenylpropanolamine—obesity	0.00219	0.0179	CcSEcCtD
Mivacurium—Doxacurium chloride—BCHE—obesity	0.00213	1	CrCbGaD
Mivacurium—Hypotension—Phenylpropanolamine—obesity	0.0021	0.0171	CcSEcCtD
Mivacurium—Tachycardia—Phentermine—obesity	0.00209	0.0171	CcSEcCtD
Mivacurium—CHRNB1—adrenal gland—obesity	0.00204	0.0352	CbGeAlD
Mivacurium—Anaphylactoid reaction—Sibutramine—obesity	0.002	0.0163	CcSEcCtD
Mivacurium—Dizziness—Methamphetamine—obesity	0.00198	0.0162	CcSEcCtD
Mivacurium—Phlebitis—Bupropion—obesity	0.00195	0.016	CcSEcCtD
Mivacurium—CHRNA2—endocrine gland—obesity	0.00191	0.0328	CbGeAlD
Mivacurium—Dizziness—Benzphetamine—obesity	0.0019	0.0156	CcSEcCtD
Mivacurium—Tachycardia—Diethylpropion—obesity	0.00182	0.0149	CcSEcCtD
Mivacurium—Anaphylactic shock—Cimetidine—obesity	0.00178	0.0145	CcSEcCtD
Mivacurium—Dizziness—Phendimetrazine—obesity	0.00174	0.0142	CcSEcCtD
Mivacurium—Tachycardia—Cimetidine—obesity	0.00173	0.0142	CcSEcCtD
Mivacurium—Urticaria—Phentermine—obesity	0.00171	0.0139	CcSEcCtD
Mivacurium—Bronchospasm—Orlistat—obesity	0.0017	0.0139	CcSEcCtD
Mivacurium—CHRM2—cardiovascular system—obesity	0.00166	0.0285	CbGeAlD
Mivacurium—CHRNB1—liver—obesity	0.0016	0.0275	CbGeAlD
Mivacurium—Urticaria—Diethylpropion—obesity	0.00148	0.0121	CcSEcCtD
Mivacurium—Dizziness—Phenylpropanolamine—obesity	0.00148	0.0121	CcSEcCtD
Mivacurium—BCHE—respiratory system—obesity	0.00144	0.0248	CbGeAlD
Mivacurium—Bronchospasm—Bupropion—obesity	0.00143	0.0117	CcSEcCtD
Mivacurium—Dizziness—Phentermine—obesity	0.00142	0.0116	CcSEcCtD
Mivacurium—Rash—Phenylpropanolamine—obesity	0.00141	0.0116	CcSEcCtD
Mivacurium—Dermatitis—Phenylpropanolamine—obesity	0.00141	0.0116	CcSEcCtD
Mivacurium—Bradycardia—Sibutramine—obesity	0.00136	0.0111	CcSEcCtD
Mivacurium—Rash—Phentermine—obesity	0.00135	0.0111	CcSEcCtD
Mivacurium—Dermatitis—Phentermine—obesity	0.00135	0.0111	CcSEcCtD
Mivacurium—Immune system disorder—Orlistat—obesity	0.00125	0.0102	CcSEcCtD
Mivacurium—Phlebitis—Topiramate—obesity	0.00125	0.0102	CcSEcCtD
Mivacurium—Mediastinal disorder—Orlistat—obesity	0.00124	0.0102	CcSEcCtD
Mivacurium—Dizziness—Diethylpropion—obesity	0.00123	0.0101	CcSEcCtD
Mivacurium—Angiopathy—Sibutramine—obesity	0.00121	0.00992	CcSEcCtD
Mivacurium—Immune system disorder—Sibutramine—obesity	0.00121	0.00987	CcSEcCtD
Mivacurium—Arrhythmia—Sibutramine—obesity	0.00119	0.00976	CcSEcCtD
Mivacurium—CHRM3—adipose tissue—obesity	0.00119	0.0205	CbGeAlD
Mivacurium—Rash—Diethylpropion—obesity	0.00118	0.00963	CcSEcCtD
Mivacurium—Dermatitis—Diethylpropion—obesity	0.00118	0.00962	CcSEcCtD
Mivacurium—Dizziness—Cimetidine—obesity	0.00117	0.00961	CcSEcCtD
Mivacurium—Muscle spasms—Orlistat—obesity	0.00116	0.00945	CcSEcCtD
Mivacurium—CHRM2—endocrine gland—obesity	0.00114	0.0196	CbGeAlD
Mivacurium—CHRM3—digestive system—obesity	0.00112	0.0193	CbGeAlD
Mivacurium—Rash—Cimetidine—obesity	0.00112	0.00916	CcSEcCtD
Mivacurium—Dermatitis—Cimetidine—obesity	0.00112	0.00915	CcSEcCtD
Mivacurium—Muscle spasms—Sibutramine—obesity	0.00112	0.00915	CcSEcCtD
Mivacurium—BCHE—cardiovascular system—obesity	0.0011	0.019	CbGeAlD
Mivacurium—Flushing—Bupropion—obesity	0.00108	0.00884	CcSEcCtD
Mivacurium—Cardiac disorder—Bupropion—obesity	0.00108	0.00884	CcSEcCtD
Mivacurium—Angiopathy—Bupropion—obesity	0.00106	0.00864	CcSEcCtD
Mivacurium—Immune system disorder—Bupropion—obesity	0.00105	0.00861	CcSEcCtD
Mivacurium—Mediastinal disorder—Bupropion—obesity	0.00105	0.00859	CcSEcCtD
Mivacurium—Arrhythmia—Bupropion—obesity	0.00104	0.00851	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00102	0.00831	CcSEcCtD
Mivacurium—Anaphylactic shock—Orlistat—obesity	0.000981	0.00802	CcSEcCtD
Mivacurium—BCHE—pituitary gland—obesity	0.000975	0.0168	CbGeAlD
Mivacurium—Muscle spasms—Bupropion—obesity	0.000975	0.00797	CcSEcCtD
Mivacurium—BCHE—adipose tissue—obesity	0.000971	0.0167	CbGeAlD
Mivacurium—Skin disorder—Orlistat—obesity	0.000953	0.00779	CcSEcCtD
Mivacurium—Anaphylactic shock—Sibutramine—obesity	0.000949	0.00776	CcSEcCtD
Mivacurium—Tachycardia—Sibutramine—obesity	0.000926	0.00758	CcSEcCtD
Mivacurium—CHRM3—endocrine gland—obesity	0.000926	0.0159	CbGeAlD
Mivacurium—Skin disorder—Sibutramine—obesity	0.000922	0.00754	CcSEcCtD
Mivacurium—BCHE—digestive system—obesity	0.000914	0.0157	CbGeAlD
Mivacurium—Hypotension—Sibutramine—obesity	0.000887	0.00726	CcSEcCtD
Mivacurium—BCHE—adrenal gland—obesity	0.000871	0.015	CbGeAlD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000857	0.00701	CcSEcCtD
Mivacurium—Anaphylactic shock—Bupropion—obesity	0.000828	0.00677	CcSEcCtD
Mivacurium—Tachycardia—Bupropion—obesity	0.000808	0.00661	CcSEcCtD
Mivacurium—Skin disorder—Bupropion—obesity	0.000804	0.00657	CcSEcCtD
Mivacurium—Urticaria—Orlistat—obesity	0.000779	0.00637	CcSEcCtD
Mivacurium—Hypotension—Bupropion—obesity	0.000773	0.00632	CcSEcCtD
Mivacurium—BCHE—endocrine gland—obesity	0.000756	0.013	CbGeAlD
Mivacurium—Bradycardia—Topiramate—obesity	0.000755	0.00618	CcSEcCtD
Mivacurium—Urticaria—Sibutramine—obesity	0.000754	0.00617	CcSEcCtD
Mivacurium—Cardiac disorder—Topiramate—obesity	0.000689	0.00563	CcSEcCtD
Mivacurium—Flushing—Topiramate—obesity	0.000689	0.00563	CcSEcCtD
Mivacurium—BCHE—liver—obesity	0.000681	0.0117	CbGeAlD
Mivacurium—Angiopathy—Topiramate—obesity	0.000673	0.00551	CcSEcCtD
Mivacurium—Immune system disorder—Topiramate—obesity	0.00067	0.00548	CcSEcCtD
Mivacurium—Mediastinal disorder—Topiramate—obesity	0.000669	0.00547	CcSEcCtD
Mivacurium—Urticaria—Bupropion—obesity	0.000657	0.00538	CcSEcCtD
Mivacurium—Dizziness—Orlistat—obesity	0.000649	0.00531	CcSEcCtD
Mivacurium—Erythema—Topiramate—obesity	0.000646	0.00528	CcSEcCtD
Mivacurium—Dizziness—Sibutramine—obesity	0.000628	0.00513	CcSEcCtD
Mivacurium—Muscle spasms—Topiramate—obesity	0.000621	0.00508	CcSEcCtD
Mivacurium—Rash—Orlistat—obesity	0.000618	0.00506	CcSEcCtD
Mivacurium—Dermatitis—Orlistat—obesity	0.000618	0.00505	CcSEcCtD
Mivacurium—Rash—Sibutramine—obesity	0.000599	0.0049	CcSEcCtD
Mivacurium—Dermatitis—Sibutramine—obesity	0.000598	0.00489	CcSEcCtD
Mivacurium—Dizziness—Bupropion—obesity	0.000547	0.00448	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000546	0.00447	CcSEcCtD
Mivacurium—Rash—Bupropion—obesity	0.000522	0.00427	CcSEcCtD
Mivacurium—Dermatitis—Bupropion—obesity	0.000521	0.00426	CcSEcCtD
Mivacurium—Tachycardia—Topiramate—obesity	0.000515	0.00421	CcSEcCtD
Mivacurium—Skin disorder—Topiramate—obesity	0.000512	0.00419	CcSEcCtD
Mivacurium—Hypotension—Topiramate—obesity	0.000493	0.00403	CcSEcCtD
Mivacurium—Urticaria—Topiramate—obesity	0.000419	0.00343	CcSEcCtD
Mivacurium—Dizziness—Topiramate—obesity	0.000349	0.00285	CcSEcCtD
Mivacurium—Rash—Topiramate—obesity	0.000332	0.00272	CcSEcCtD
Mivacurium—Dermatitis—Topiramate—obesity	0.000332	0.00272	CcSEcCtD
Mivacurium—CHRM2—GPCR downstream signaling—AGT—obesity	1.96e-05	0.000123	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR1B—obesity	1.94e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CRH—obesity	1.94e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SDC1—obesity	1.94e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCD—obesity	1.93e-05	0.000122	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LPL—obesity	1.93e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SDC1—obesity	1.92e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCD—obesity	1.91e-05	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKR1C3—obesity	1.9e-05	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR2A—obesity	1.89e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—C3—obesity	1.89e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GCG—obesity	1.89e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—SLC2A4—obesity	1.89e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKR1C3—obesity	1.89e-05	0.000119	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GPX1—obesity	1.88e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR2A—obesity	1.87e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—C3—obesity	1.87e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYCS—obesity	1.86e-05	0.000117	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NPS—obesity	1.86e-05	0.000117	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NPS—obesity	1.84e-05	0.000116	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CD36—obesity	1.83e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GOT1—obesity	1.83e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GGT1—obesity	1.83e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—F2—obesity	1.82e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PRKCB—obesity	1.82e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DRD1—obesity	1.82e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2C—obesity	1.82e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—F2—obesity	1.81e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PRKCB—obesity	1.81e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DRD1—obesity	1.8e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2C—obesity	1.8e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NCOA1—obesity	1.8e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGT—obesity	1.79e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGT—obesity	1.78e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—STK11—obesity	1.77e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP19A1—obesity	1.77e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NTRK2—obesity	1.77e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB1—obesity	1.76e-05	0.000111	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NTRK2—obesity	1.75e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CG—obesity	1.75e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB1—obesity	1.75e-05	0.00011	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—obesity	1.73e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CG—obesity	1.73e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GHRL—obesity	1.73e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PARP1—obesity	1.73e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DRD4—obesity	1.71e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GHRL—obesity	1.71e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PARP1—obesity	1.71e-05	0.000108	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARA—obesity	1.7e-05	0.000107	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DRD4—obesity	1.69e-05	0.000107	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—POMC—obesity	1.66e-05	0.000105	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—F2—obesity	1.66e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCB—obesity	1.66e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—COMT—obesity	1.65e-05	0.000104	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AGT—obesity	1.65e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—POMC—obesity	1.65e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCB—obesity	1.64e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2—obesity	1.64e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CNR1—obesity	1.63e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARGC1A—obesity	1.63e-05	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNB3—obesity	1.63e-05	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—obesity	1.62e-05	0.000102	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CNR1—obesity	1.62e-05	0.000102	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—obesity	1.61e-05	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TCF7L2—obesity	1.61e-05	0.000101	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CAV1—obesity	1.6e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT2—obesity	1.6e-05	0.000101	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOA1—obesity	1.6e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DRD2—obesity	1.59e-05	0.0001	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TCF7L2—obesity	1.59e-05	0.0001	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CG—obesity	1.59e-05	9.99e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNAS—obesity	1.58e-05	9.98e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT2—obesity	1.58e-05	9.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DRD2—obesity	1.58e-05	9.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GCG—obesity	1.58e-05	9.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTPN1—obesity	1.58e-05	9.94e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CG—obesity	1.57e-05	9.89e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GCG—obesity	1.56e-05	9.84e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTPN1—obesity	1.56e-05	9.84e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOB—obesity	1.55e-05	9.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CD—obesity	1.54e-05	9.67e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.53e-05	9.63e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CD—obesity	1.52e-05	9.58e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—POMC—obesity	1.51e-05	9.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRL—obesity	1.51e-05	9.48e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—POMC—obesity	1.49e-05	9.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRL—obesity	1.49e-05	9.39e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STK11—obesity	1.48e-05	9.35e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPL—obesity	1.48e-05	9.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL2—obesity	1.48e-05	9.3e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STK11—obesity	1.47e-05	9.26e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLG—obesity	1.47e-05	9.24e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—RHOA—obesity	1.46e-05	9.23e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL2—obesity	1.46e-05	9.21e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CG—obesity	1.46e-05	9.18e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLG—obesity	1.45e-05	9.15e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT2—obesity	1.45e-05	9.14e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—RHOA—obesity	1.45e-05	9.14e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3R1—obesity	1.45e-05	9.13e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GPX1—obesity	1.44e-05	9.1e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT2—obesity	1.44e-05	9.05e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3R1—obesity	1.44e-05	9.04e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FOXO3—obesity	1.43e-05	9.02e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB2—obesity	1.43e-05	9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FOXO3—obesity	1.42e-05	8.93e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB2—obesity	1.41e-05	8.91e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD36—obesity	1.41e-05	8.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS1—obesity	1.41e-05	8.86e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—obesity	1.41e-05	8.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CD—obesity	1.39e-05	8.78e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS1—obesity	1.39e-05	8.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS3—obesity	1.39e-05	8.75e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—POMC—obesity	1.39e-05	8.74e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CD—obesity	1.38e-05	8.7e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—INS—obesity	1.38e-05	8.69e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS3—obesity	1.38e-05	8.67e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNB3—obesity	1.36e-05	8.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNB3—obesity	1.35e-05	8.48e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—TYK2—obesity	1.34e-05	8.45e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CB—obesity	1.34e-05	8.43e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF2—obesity	1.34e-05	8.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—obesity	1.33e-05	8.4e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—RHOA—obesity	1.33e-05	8.38e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—TYK2—obesity	1.33e-05	8.37e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CB—obesity	1.33e-05	8.35e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNAS—obesity	1.32e-05	8.34e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF2—obesity	1.32e-05	8.33e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—RHOA—obesity	1.32e-05	8.3e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3R1—obesity	1.32e-05	8.29e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNAS—obesity	1.31e-05	8.26e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARA—obesity	1.31e-05	8.24e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.3e-05	8.21e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOB—obesity	1.3e-05	8.17e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOB—obesity	1.28e-05	8.09e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CD—obesity	1.28e-05	8.07e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AGT—obesity	1.27e-05	7.98e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL5—obesity	1.27e-05	7.98e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—obesity	1.26e-05	7.96e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL5—obesity	1.25e-05	7.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—obesity	1.24e-05	7.82e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LPL—obesity	1.24e-05	7.8e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAV1—obesity	1.23e-05	7.75e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FOXO1—obesity	1.23e-05	7.74e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.23e-05	7.73e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA1—obesity	1.23e-05	7.73e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LPL—obesity	1.23e-05	7.72e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FOXO1—obesity	1.22e-05	7.67e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.22e-05	7.66e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.22e-05	7.65e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3R1—obesity	1.21e-05	7.62e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—obesity	1.21e-05	7.62e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.2e-05	7.58e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCD—obesity	1.14e-05	7.19e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCD—obesity	1.13e-05	7.12e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CG—obesity	1.12e-05	7.06e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2A—obesity	1.12e-05	7.03e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CB—obesity	1.12e-05	7.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—C3—obesity	1.11e-05	7.02e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—obesity	1.11e-05	6.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2A—obesity	1.11e-05	6.96e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—C3—obesity	1.1e-05	6.96e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—obesity	1.08e-05	6.81e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—POMC—obesity	1.07e-05	6.72e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IRS2—obesity	1.06e-05	6.68e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—INS—obesity	1.06e-05	6.68e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGT—obesity	1.06e-05	6.67e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IRS2—obesity	1.05e-05	6.62e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGT—obesity	1.05e-05	6.61e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—obesity	1.04e-05	6.54e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LEP—obesity	1.04e-05	6.54e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CAV1—obesity	1.03e-05	6.48e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—obesity	1.03e-05	6.48e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LEP—obesity	1.03e-05	6.48e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA1—obesity	1.03e-05	6.46e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CAV1—obesity	1.02e-05	6.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA1—obesity	1.02e-05	6.4e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ESR1—obesity	9.91e-06	6.24e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CD—obesity	9.85e-06	6.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ESR1—obesity	9.81e-06	6.18e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCB—obesity	9.79e-06	6.17e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2—obesity	9.79e-06	6.17e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—obesity	9.72e-06	6.12e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2—obesity	9.69e-06	6.11e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCB—obesity	9.69e-06	6.11e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BAD—obesity	9.67e-06	6.09e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BAD—obesity	9.58e-06	6.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CG—obesity	9.37e-06	5.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3R1—obesity	9.3e-06	5.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—obesity	9.3e-06	5.86e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CG—obesity	9.28e-06	5.84e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IRS1—obesity	9.26e-06	5.83e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IRS1—obesity	9.17e-06	5.78e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—POMC—obesity	8.92e-06	5.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—INS—obesity	8.87e-06	5.59e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—POMC—obesity	8.83e-06	5.56e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—INS—obesity	8.78e-06	5.53e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL2—obesity	8.72e-06	5.5e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL2—obesity	8.64e-06	5.44e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CB—obesity	8.58e-06	5.41e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—obesity	8.58e-06	5.4e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT2—obesity	8.57e-06	5.4e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—obesity	8.51e-06	5.36e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—obesity	8.49e-06	5.35e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT2—obesity	8.49e-06	5.35e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CD—obesity	8.24e-06	5.19e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CA—obesity	8.16e-06	5.14e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CD—obesity	8.16e-06	5.14e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SERPINE1—obesity	8.15e-06	5.13e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CA—obesity	8.08e-06	5.09e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SERPINE1—obesity	8.07e-06	5.08e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TYK2—obesity	7.92e-06	4.99e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RHOA—obesity	7.86e-06	4.95e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TYK2—obesity	7.85e-06	4.94e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RHOA—obesity	7.78e-06	4.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3R1—obesity	7.78e-06	4.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—obesity	7.78e-06	4.9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—obesity	7.7e-06	4.85e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3R1—obesity	7.7e-06	4.85e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CA—obesity	7.41e-06	4.67e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CA—obesity	7.34e-06	4.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MTOR—obesity	7.18e-06	4.52e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CB—obesity	7.18e-06	4.52e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MTOR—obesity	7.11e-06	4.48e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CB—obesity	7.11e-06	4.48e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CA—obesity	6.81e-06	4.29e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—obesity	6.66e-06	4.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—obesity	6.6e-06	4.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—obesity	6.56e-06	4.13e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—obesity	6.5e-06	4.09e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—obesity	6.24e-06	3.93e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—obesity	6.18e-06	3.89e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK8—obesity	6.07e-06	3.82e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—obesity	6.05e-06	3.81e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK8—obesity	6.01e-06	3.79e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—obesity	5.99e-06	3.77e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—obesity	5.56e-06	3.5e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT3—obesity	5.55e-06	3.49e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT3—obesity	5.49e-06	3.46e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CA—obesity	5.23e-06	3.3e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MYC—obesity	5.15e-06	3.25e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—obesity	5.14e-06	3.24e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MYC—obesity	5.1e-06	3.22e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—obesity	5.09e-06	3.21e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CA—obesity	4.38e-06	2.76e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CA—obesity	4.33e-06	2.73e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—obesity	4.28e-06	2.69e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—obesity	3.87e-06	2.44e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—obesity	3.84e-06	2.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—obesity	3.57e-06	2.25e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—obesity	3.54e-06	2.23e-05	CbGpPWpGaD
